|  | CD4+Ki-67+(%) | CD4+PD-L1+(%) | CD4+PD-1+(%) | CD19+Ki-67+(%) | CD19+PD-L1+(%) |
---|---|---|---|---|---|---|
HC | CD4+PD-L1+(%) | 0.094 | Â | Â | Â | Â |
CD4+PD-1+(%) | 0.332* | 0.576** | Â | Â | Â | |
CD19+Ki-67+(%) | 0.384* | 0.149 | 0.184 | Â | Â | |
CD19+PD-L1+(%) | -0.155 | 0.512** | 0.452** | 0.192 | Â | |
CD19+PD-1+(%) | -0.144 | 0.403** | 0.638** | -0.058 | 0.597** | |
SLE | CD4+PD-L1+(%) | -0.064 | Â | Â | Â | Â |
CD4+PD-1+(%) | 0.201 | 0.106 | Â | Â | Â | |
CD19+Ki-67+(%) | 0.323* | -0.063 | -0.111 | Â | Â | |
CD19+PD-L1+(%) | -0.021 | 0.098 | -0.015 | -0.011 | Â | |
CD19+PD-1+(%) | -0.110 | -0.003 | 0.257 | -0.006 | 0.572** |